Previous 10 |
home / stock / dose:cc / dose:cc news
Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, today announced that it plans to complete a private placement financing (the “ Financing ”) for ...
Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is pleased to announce the closing of the first tranche of a Private Placement. The tranche consists of 506,15...
Rapid Dose Therapeutics Corp. (“ RDT ”), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, provides the following update regarding the signing of a number of strategically significant agreements with Oakla...
Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform and Skycare Compounding Labs ( “Skycare” ) a leader in compou...
News, Short Squeeze, Breakout and More Instantly...
Rapid Dose Therapeutics Corp. Company Name:
DOSE:CC Stock Symbol:
CNQC Market:
Rapid Dose Therapeutics Corp. Website:
Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the " Financing ") for aggregate gross proceeds ...
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") announced today that as contemplated in the secured convertible notes (the " Notes ") previously issued on its private placement financing (the " Financing "), the Company...
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company "), is pleased to announce the filing of its financial results for the year ended February 29, 2024. Mark Upsdell, Chairman and Chief Executive Officer, stated, "Over ...